Zhitong Financial App News, Saisheng Pharmaceutical (300485.SZ) released a report for the third quarter of 2023, the company's operating income in the first three quarters was 394 million yuan, down 34.28% from the same period last year. The net profit belonging to shareholders of listed companies was 197 million yuan, down 22.21% from the same period last year. The net profit after deducting non-recurring gains and losses belonging to shareholders of listed companies was 22.2875 million yuan, down 49.95% from the same period last year. The basic earnings per share is 0.41 yuan.
赛升药业(300485.SZ)发布前三季度业绩，净利润1.97亿元，下降22.21%
Saisheng Pharmaceutical (300485.SZ) released results for the first three quarters, with net profit of 197 million yuan, a decrease of 22.21%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.